Ayala Pharmaceuticals Inc (ADXS)

[equaloppforall]

I agree. I don't want a sweetheart private placement that helps the shorts to happen. But I wouldn't be completely shocked if ADXS met them halfway - enough to help their favored funds, primarily Adage and Fidelity - but screwing over the rest in a short squeeze with the favored funds' help. Sweetheart deals are known to happen in the biotech world quite often. I invested in ADXS because I greatly believe in the platform and to a degree in the efficiency (generally speaking) of management to advance the science through the clinic and the FDA, but not their business ethics. Most biotech CEOs and managements are opportunists (mostly due to greed but sometimes due to a lack of choice).

Look at the recent INO dilution to the tune of $75 million. The CEO is also a scientist but he never loses a chance to screw over retail. To ADXS' credit, they have never diluted their retail holders to the degree that many other biotechs have diluted theirs. Touch wood, I don't intend to jinx that record.